Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy ...

HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Trial of HTX-001, an Investigational Cellular Reprogramming Therapy ...

Researchers evaluated an allogeneic umbilical cord cell therapy in T1DM. A single dose provided durable insulin preservation, ...

With global life expectancy steadily increasing, the growing gap between lifespan and healthspan has placed the aging of the ...

Paligenosis defines a tightly controlled program through which terminally differentiated cells re‑enter the cell cycle and ...

A new stem-cell-derived model suggests human pancreatic cells require multiple genetic failures before becoming cancerous and ...

Longevity science races to slow ageing, from AI driven drug discovery to cellular rejuvenation, with leaders like David ...

The immune system exhibits remarkable plasticity, enabling dynamic responses to environmental cues while maintaining tissue homeostasis. Emerging evidence ...

Chronic lung diseases, such as COPD, pulmonary fibrosis and BPD, impose heavy global health burdens with high morbidity and mortality. Recent studies have ...

Farmers have spent decades adding inputs to farming. What comes next is something fundamentally different – reprogramming the ...

MiNK Therapeutics Inc (INKT) showcases promising clinical progress and strategic collaborations, while navigating financial hurdles and development risks.

The most significant transformation will be AI acting as a unifying intelligence layer, linking robotics to an expansive ...